Hrt Financial LP Opgen Inc Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.12 - $62.0 $22,972 - $11.9 Million
191,437 New
191,437 $26,000
Q2 2022

Aug 12, 2022
SELL
$0.32 - $0.79 $5,043 - $12,450
-15,760 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.72 - $1.11 $11,347 - $17,493
15,760 New
15,760 $11,000
Q2 2021

Aug 16, 2021
SELL
$1.95 - $2.8 $24,016 - $34,484
-12,316 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.8 - $3.55 $22,168 - $43,721
12,316 New
12,316 $30,000

Others Institutions Holding OPGN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About OPGEN INC

OPGN Quotes by TradingView
  • Ticker OPGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,698,500
  • Market Cap $63.4M
  • Description
  • OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...
More about OPGN
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email